Argatroban Injection Trademark Details

This mark is dead with a status of Abandoned-Failure to Respond or Late Response. The last case file activity for this mark occured 20 years ago on Saturday, January 24, 2004, according to the United State Patent & Trademark Office
Word Mark Argatroban Injection
Status Dead 602 — Abandoned-Failure to Respond or Late Response

Current Owner

Texas Biotechnology Corporation of Houston, TX

View all trademarks for Texas Biotechnology Corporation
Other Trademarks for Texas Biotechnology Corporation
Serial Number 76161856
Status Date Saturday, January 24, 2004
Filing Date Saturday, January 24, 2004
Attorney Martin L. Katz

Correspondent

MARTIN L. KATZ
WOOD, PHILLIPS, KATZ, CLARK & MORTIMER
CITICORP CENTER, SUITE 3800
500 WEST MADISON STREET
CHICAGO IL 60661-2511

Case File Statements

Disclaimer with Predetermined Text "Injection"
Goods & Services Pharmaceutical product for use as an anticoagulant and for the treatment of heparin-induced thrombocytopenia with or without thrombosis, acute coronary syndromes, ischemic stroke, percutaneous coronary interventions, venous thrombosis, arterial thrombosis, coagulopathies, pulmonary embolism, peripheral embolism and hemodialysis

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Friday, November 17, 2000
First Use Anywhere Thursday, November 30, 2000
First Use In Commerce Thursday, November 30, 2000
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.